NLRC5: A newly discovered MHC class I transactivator (CITA)

Microbes and Infection

Volumn 14, Issue 6, 2012, Pages 477-484

  Meissner, Torsten B ^a   Li, Amy ^a   Kobayashi, Koichi S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CIITA; MHC class I; NLR proteins

Indexed keywords

CYTOKINE; INFLAMMASOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MHC CLASS I TRANSACTIVATOR PROTEIN; NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT C5 PROTEIN; NUCLEOTIDE BINDING PROTEIN; RECEPTOR; REGULATOR PROTEIN; RIG I LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; HUMAN; INFECTION; MOLECULAR MODEL; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; TRANS-ACTIVATORS;

EID: 84860457505     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.12.007     Document Type: Short Survey

References (67)

1. Germain R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994, 76:287-299.
2. Reith W., Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 2001, 19:331-373.
3. Ting J.P., Trowsdale J. Genetic control of MHC class II expression. Cell 2002, 109(Suppl 2):S21-S33.
4. Choi N.M., Majumder P., Boss J.M. Regulation of major histocompatibility complex class II genes. Curr. Opin. Immunol. 2011, 23:81-87.
5. Meissner T.B., Li A., Biswas A., Lee K.H., Liu Y.J., Bayir E., Iliopoulos D., van den Elsen P.J., Kobayashi K.S. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:13794-13799.
6. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 1998, 16:323-358.
7. Braud V.M., Allan D.S., McMichael A.J. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 1999, 11:100-108.
8. Le Bouteiller P., Solier C. Is antigen presentation the primary function of HLA-G?. Microb. Infect. 2001, 3:323-332.
9. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 1993, 11:403-450.
10. Oldstone M.B. Virus-lymphoid cell interactions. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:12756-12758.
11. Shastri N., Cardinaud S., Schwab S.R., Serwold T., Kunisawa J. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 2005, 207:31-41.
12. Peaper D.R., Cresswell P. Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell Dev. Biol. 2008, 24:343-368.
13. Lanier L.L. Natural killer cell receptors and MHC class I interactions. Curr. Opin. Immunol. 1997, 9:126-131.
14. Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M.C., Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997, 155:105-117.
15. Ting J.P., Lovering R.C., Alnemri E.S., Bertin J., Boss J.M., Davis B.K., Flavell R.A., Girardin S.E., Godzik A., Harton J.A., Hoffman H.M., Hugot J.P., Inohara N., Mackenzie A., Maltais L.J., Nunez G., Ogura Y., Otten L.A., Philpott D., Reed J.C., Reith W., Schreiber S., Steimle V., Ward P.A. The NLR gene family: a standard nomenclature. Immunity 2008, 28:285-287.
16. Wilmanski J.M., Petnicki-Ocwieja T., Kobayashi K.S. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol. 2008, 83:13-30.
17. Franchi L., Warner N., Viani K., Nunez G. Function of nod-like receptors in microbial recognition and host defense. Immunol. Rev. 2009, 227:106-128.
18. Koonin E.V., Aravind L. The NACHT family-a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem. Sci. 2000, 25:223-224.
19. Tschopp J., Martinon F., Burns K. NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 2003, 4:95-104.
20. Bertin J., DiStefano P.S. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 2000, 7:1273-1274.
21. Inohara N., Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 2001, 20:6473-6481.
22. Martinon F., Hofmann K., Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 2001, 11:R118-R120.
23. Fairbrother W.J., Gordon N.C., Humke E.W., O'Rourke K.M., Starovasnik M.A., Yin J.P., Dixit V.M. The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci. 2001, 10:1911-1918.
24. Pawlowski K., Pio F., Chu Z., Reed J.C., Godzik A. PAAD-a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 2001, 26:85-87.
25. Weber C.H., Vincenz C. The death domain superfamily: a tale of two interfaces?. Trends Biochem. Sci. 2001, 26:475-481.
26. Staub E., Dahl E., Rosenthal A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem. Sci. 2001, 26:83-85.
27. Birnbaum M.J., Clem R.J., Miller L.K. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J. Virol. 1994, 68:2521-2528.
28. Elinav E., Strowig T., Henao-Mejia J., Flavell R.A. Regulation of the antimicrobial response by NLR proteins. Immunity 2011, 34:665-679.
29. A. Biswas, T. Petnicki-Ocwieja, K.S. Kobayashi, Nod2: a key regulator linking microbiota to intestinal mucosal immunity, J. Mol. Med., 2011 Aug 23. [Epub ahead of print].
30. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
31. Tong Z.B., Gold L., Pfeifer K.E., Dorward H., Lee E., Bondy C.A., Dean J., Nelson L.M. Mater, a maternal effect gene required for early embryonic development in mice. Nat. Genet. 2000, 26:267-268.
32. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993, 75:135-146.
33. Ting J.P., Willingham S.B., Bergstralh D.T. NLRs at the intersection of cell death and immunity. Nat. Rev. Immunol. 2008, 8:372-379.
34. Reith W., LeibundGut-Landmann S., Waldburger J.M. Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 2005, 5:793-806.
35. Bewry N.N., Bolick S.C., Wright K.L., Harton J.A. GTP-dependent recruitment of CIITA to the class II major histocompatibility complex promoter. J. Biol. Chem. 2007, 282:26178-26184.
36. Spilianakis C., Papamatheakis J., Kretsovali A. Acetylation by PCAF enhances CIITA nuclear accumulation and transactivation of major histocompatibility complex class II genes. Mol. Cell. Biol. 2000, 20:8489-8498.
37. Cressman D.E., O'Connor W.J., Greer S.F., Zhu X.S., Ting J.P. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator. J. Immunol. 2001, 167:3626-3634.
38. Raval A., Weissman J.D., Howcroft T.K., Singer D.S. The GTP-binding domain of class II transactivator regulates its nuclear export. J. Immunol. 2003, 170:922-930.
39. DeSandro A., Nagarajan U.M., Boss J.M. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am. J. Hum. Genet. 1999, 65:279-286.
40. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 1994, 265:106-109.
41. LeibundGut-Landmann S., Waldburger J.M., Krawczyk M., Otten L.A., Suter T., Fontana A., Acha-Orbea H., Reith W. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 2004, 34:1513-1525.
42. Beresford G.W., Boss J.M. CIITA coordinates multiple histone acetylation modifications at the HLA-DRA promoter. Nat. Immunol. 2001, 2:652-657.
43. Masternak K., Muhlethaler-Mottet A., Villard J., Zufferey M., Steimle V., Reith W. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 2000, 14:1156-1166.
44. van den Elsen P.J., Gobin S.J., van Eggermond M.C., Peijnenburg A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 1998, 48:208-221.
45. van den Elsen P.J., Peijnenburg A., van Eggermond M.C., Gobin S.J. Shared regulatory elements in the promoters of MHC class I and class II genes. Immunol. Today 1998, 19:308-312.
46. Boss J.M., Jensen P.E. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 2003, 15:105-111.
47. Martin B.K., Chin K.C., Olsen J.C., Skinner C.A., Dey A., Ozato K., Ting J.P. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997, 6:591-600.
48. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:4285-4288.
49. Chang C.H., Guerder S., Hong S.C., van Ewijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 1996, 4:167-178.
50. Itoh-Lindstrom Y., Piskurich J.F., Felix N.J., Wang Y., Brickey W.J., Platt J.L., Koller B.H., Ting J.P. Reduced IL-4-, lipopolysaccharide-, and IFN-gamma-induced MHC class II expression in mice lacking class II transactivator due to targeted deletion of the GTP-binding domain. J. Immunol. 1999, 163:2425-2431.
51. Williams G.S., Malin M., Vremec D., Chang C.H., Boyd R., Benoist C., Mathis D. Mice lacking the transcription factor CIITA-a second look. Int. Immunol. 1998, 10:1957-1967.
52. Kuenzel S., Till A., Winkler M., Hasler R., Lipinski S., Jung S., Grotzinger J., Fickenscher H., Schreiber S., Rosenstiel P. The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses. J. Immunol. 2010, 184:1990-2000.
53. Neerincx A., Lautz K., Menning M., Kremmer E., Zigrino P., Hosel M., Buning H., Schwarzenbacher R., Kufer T.A. A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses. J. Biol. Chem. 2010, 285:26223-26232.
54. Benko S., Magalhaes J.G., Philpott D.J., Girardin S.E. NLRC5 limits the activation of inflammatory pathways. J. Immunol. 2010, 185:1681-1691.
55. Martinon F., Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 2005, 26:447-454.
56. Nickerson K., Sisk T.J., Inohara N., Yee C.S., Kennell J., Cho M.C., Yannie P.J., Nunez G., Chang C.H. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. J. Biol. Chem. 2001, 276:19089-19093.
57. Cressman D.E., Chin K.C., Taxman D.J., Ting J.P. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 1999, 10:163-171.
58. Chang C.H., Fontes J.D., Peterlin M., Flavell R.A. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 1994, 180:1367-1374.
59. Muhlethaler-Mottet A., Di Berardino W., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 1998, 8:157-166.
60. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 1998, 160:233-240.
61. Piskurich J.F., Linhoff M.W., Wang Y., Ting J.P. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol. Cell Biol. 1999, 19:431-440.
62. Wright K.L., Chin K.C., Linhoff M., Skinner C., Brown J.A., Boss J.M., Stark G.R., Ting J.P. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6267-6272.
63. Hanson P.I., Whiteheart S.W. AAA+ proteins: have engine, will work. Nat. Rev. Mol. Cell Biol. 2005, 6:519-529.
64. Gobin S.J., Peijnenburg A., Keijsers V., van den Elsen P.J. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997, 6:601-611.
65. Cui J., Zhu L., Xia X., Wang H.Y., Legras X., Hong J., Ji J., Shen P., Zheng S., Chen Z.J., Wang R.F. NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. Cell 2010, 141:483-496.
66. Kumar H., Pandey S., Zou J., Kumagai Y., Takahashi K., Akira S., Kawai T. NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. J. Immunol. 2011, 186:994-1000.
67. Davis B.K., Roberts R.A., Huang M.T., Willingham S.B., Conti B.J., Brickey W.J., Barker B.R., Kwan M., Taxman D.J., Accavitti-Loper M.A., Duncan J.A., Ting J.P. Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 2011, 186:1333-1337.